Feasibility Study of an Angiographic Quantitative Flow Ratio-guided Endovascular Procedure in Patients With Lower Limbs Peripheral Arterial Disease.
QFR
2 other identifiers
interventional
35
1 country
1
Brief Summary
The main objective of this study is to explore the feasibility of using the angiographic Quantitative Flow Ratio (QFR) as a tool to predict the success rate of endovascular revascularization in patients with superficial artery disease. This is a prospective feasibility study. We aim to include 35 patients with indication for endovascular revascularization of a short stenosis of the superficial femoral artery. Intraoperative angiography will be performed immediately prior to revascularization. Quantitative analysis of angiography images will be performed post-procedure using Medis QFR®2.2 software.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 29, 2024
CompletedFirst Submitted
Initial submission to the registry
July 10, 2024
CompletedFirst Posted
Study publicly available on registry
July 23, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 24, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 24, 2025
CompletedJuly 23, 2024
July 1, 2024
12 months
July 10, 2024
July 18, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Preoperative systolic velocity peak and intraoperative QFR
Systolic velocity peak measured by preoperative ultrasound, performed the day before or the day of surgery, and QFR measured intraoperatively, immediately before the revascularization procedure.
Day -1, Day 0
Secondary Outcomes (8)
Percentage of stenosis
Day -1, Day 0
Occurrence of a Major Adverse Limb Event (MALE)
Day 30
Re-hospitalization
Day 30
Revascularization
Day 30
Rutherford classification
Day 30
- +3 more secondary outcomes
Study Arms (1)
qfr
EXPERIMENTALPatients with indication for endovascular revascularization of a short stenosis of the superficial femoral artery (TASC A, Rutherford stage 2 to 6) : * Preoperative ultrasound, performed the day before or the day of surgery * Intraoperative angiography performed immediately prior to revascularization (routine care procedure whose duration is extended by research) * Quantitative analysis of angiography images will be performed post-procedure using Medis QFR®2.2 software.
Interventions
Preoperative ultrasound examination performed the day before or the day of surgery.
Intraoperative angiography will be performed immediately prior to revascularization. Quantitative analysis of angiography images will be performed post-procedure using Medis QFR®2.2 software.
Eligibility Criteria
You may qualify if:
- Patient with symptomatic Rutherford stage 2 to 6 AOMI with an indication for endovascular revascularization
- Patient with a simple lesion (TASC A) and short stenosis of the superficial femoral artery
- Patient affiliated to a health insurance system
- French-speaking patient
- Patient with free, informed and express oral consent
You may not qualify if:
- Renal failure patients with GFR \< 30 ml/min
- Patient deprived of liberty
- Patients under court protection
- Pregnant or breast-feeding patients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Fondation Hôpital Saint-Josephlead
- Medis Medical Imaging Systems B.V.collaborator
Study Sites (1)
Hôpital Paris Saint-Joseph - 185 Rue Raymond Losserand
Paris, Île-de-France Region, 750014, France
Study Officials
- PRINCIPAL INVESTIGATOR
Maxime RAUX, Principal investigator
Fondation Hôpital Saint-Joseph
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 10, 2024
First Posted
July 23, 2024
Study Start
April 29, 2024
Primary Completion
April 24, 2025
Study Completion
May 24, 2025
Last Updated
July 23, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share